Rockbridge Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-611
Closed -$50.3K – 417
2023
Q4
$50.3K Buy
+611
New +$46.6K 0.01% 241
2022
Q3
– Sell
-340
Closed -$30.5K – 395
2022
Q2
$30.5K Sell
340
-796
-70% -$80.7K 0.01% 262
2022
Q1
$128K Sell
1,136
-400
-26% -$42.3K 0.02% 196
2021
Q4
$159K Hold
1,536
– – 0.02% 200
2021
Q3
$193K Sell
1,536
-13
-0.8% -$1.68K 0.03% 155
2021
Q2
$192K Buy
1,549
+400
+35% +$50.2K 0.03% 155
2021
Q1
$136K Sell
1,149
-740
-39% -$86.7K 0.03% 181
2020
Q4
$221K Buy
1,889
+814
+76% +$89.6K 0.05% 129
2020
Q3
$112K Buy
1,075
+385
+56% +$38.7K 0.03% 176
2020
Q2
$63K Buy
+690
New +$66.2K 0.02% 215

Other funds holding MDT

Rockbridge Investment Management's MDT Position: Q1 2024 in Review

Rockbridge Investment Management sold out of Medtronic (MDT) in Q1 2024, closing a stake of 611 shares — an estimated $50.3K sold.

Rockbridge Investment Management first reported a position in MDT in Q2 2020 and held it in 10 quarters. The position peaked at $221K in Q4 2020. 2,081 funds tracked by Wall St. Rank hold MDT as of Q1 2024.

  • Rockbridge Investment Management reported no remaining Medtronic position as of Q1 2024 after selling out during the quarter.
  • Rockbridge Investment Management sold 611 Medtronic shares in Q1 2024, an estimated $50.3K.
  • Rockbridge Investment Management first reported a position in Medtronic in Q2 2020 and held it in 10 quarters.
  • Rockbridge Investment Management's Medtronic position peaked at $221K in Q4 2020.
  • 2,081 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.

Based on Rockbridge Investment Management's 13F filing for Q1 2024, filed 15 May 2024.